Sitafloxacin-Based Third-Line Eradication of H. pylori

被引:0
|
作者
Suzuki, Hidekazu
Matsuzaki, Juntaro
Nishizawa, Toshihiro
Saito, Yoshimasa
Hirata, Kenro
Tsugawa, Hitoshi
Muraoka, Hiroe
Hibi, Toshifumi
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
M1139
引用
收藏
页码:S340 / S340
页数:1
相关论文
共 50 条
  • [31] Eradication of Helicobacter pylori with 10-Day Sitafloxacin-based Triple Therapy as a Third- or Fourth-Line Rescue Therapy: Preliminary Results of Open-Label Randomized Trial
    Mori, Hideki
    Suzuki, Hidekazu
    Matsuzaki, Juntaro
    Fukuhara, Seiichiro
    Okada, Sawako
    Hirata, Kenro
    Tsugawa, Hitoshi
    Hibi, Toshifumi
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S56 - S57
  • [32] The Status of Drug Resistant H. pylori in Past 20 Years (1995-2014) and the Usefulness of Sitafloxacin for H. pylori Eradication Therapy in Japan
    Tanaka, Akifumi
    Tokunaga, Kengo
    Mori, Hideaki
    Hisamatsu, Tadakazu
    Takahashi, Shin'ichi
    [J]. DIGESTION, 2017, 95 (01) : 93 - 94
  • [33] Efficacy of levofloxacin-based third-line therapy for the eradication of Helicobacter pylori in central Seoul, Korea
    Moon, J.
    Lee, D.
    Shin, Y.
    Lee, S.
    Park, T.
    Ryu, S.
    Kim, Y.
    Seol, S.
    [J]. HELICOBACTER, 2019, 24
  • [34] Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease
    Lim, Joo Hyun
    Kim, Sang Gyun
    Song, Ji Hyun
    Hwang, Jae Jin
    Lee, Dong Ho
    Han, Jae Pil
    Hong, Su Jin
    Kim, Ji Hyun
    Jeon, Seong Woo
    Kim, Gwang Ha
    Shim, Ki-Nam
    Shin, Woon Geon
    Kim, Tae Ho
    Kim, Sun Moon
    Chung, Ii-Kwon
    Kim, Hyun-Soo
    Kim, Heung Up
    Lee, Joongyub
    Kim, Jae Gyu
    [J]. GUT AND LIVER, 2017, 11 (02) : 226 - 231
  • [35] Outcome of second- and third-line Helicobacter pylori eradication therapies based on antimicrobial susceptibility testing
    Draeger, Sarah
    Wueppenhorst, Nicole
    Kist, Manfred
    Glocker, Erik-Oliver
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (11) : 3141 - 3145
  • [36] Dual therapy for third-line Helicobacter pylori eradication and urea breath test prediction
    Nishizawa, Toshihiro
    Suzuki, Hidekazu
    Maekawa, Takama
    Harada, Naohiko
    Toyokawa, Tatsuya
    Kuwai, Toshio
    Ohara, Masanori
    Suzuki, Takahiro
    Kawanishi, Masahiro
    Noguchi, Kenji
    Yoshio, Toshiyuki
    Katsushima, Shinji
    Tsuruta, Hideo
    Masuda, Eiji
    Tanaka, Munehiro
    Katayama, Shunsuke
    Kawamura, Norio
    Nishizawa, Yuko
    Hibi, Toshifumi
    Takahashi, Masahiko
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (21) : 2735 - 2738
  • [37] Dual therapy for third-line Helicobacter pylori eradication and urea breath test prediction
    Toshihiro Nishizawa
    Hidekazu Suzuki
    Takama Maekawa
    Naohiko Harada
    Tatsuya Toyokawa
    Toshio Kuwai
    Masanori Ohara
    Takahiro Suzuki
    Masahiro Kawanishi
    Kenji Noguchi
    Toshiyuki Yoshio
    Shinji Katsushima
    Hideo Tsuruta
    Eiji Masuda
    Munehiro Tanaka
    Shunsuke Katayama
    Norio Kawamura
    Yuko Nishizawa
    Toshifumi Hibi
    Masahiko Takahashi
    [J]. World Journal of Gastroenterology, 2012, (21) : 2735 - 2738
  • [39] Third-line levofloxacin-based rescue regimen in patients with two H-pylori eradication failures:: A Spanish multicenter study
    Gisbert, Javier F.
    Catro-fernandez, M.
    Bermejo, F.
    Perez-aisa, A.
    Ducons, J.
    Fernandez-bermejo, M.
    Cosme, A.
    Bory, F.
    Benito, L. M.
    Lopez-rivas, L.
    Lamas, E.
    Carneros, J. A.
    Pahon, M.
    Valer, P.
    [J]. GASTROENTEROLOGY, 2007, 132 (04) : A611 - A611
  • [40] Efficacy of Sitafloxacin-Based Rescue Therapy for Helicobacter pylori after Failures of First- and Second-Line Therapies
    Matsuzaki, Juntaro
    Suzuki, Hidekazu
    Nishizawa, Toshihiro
    Hirata, Kenro
    Tsugawa, Hitoshi
    Saito, Yoshimasa
    Okada, Sawako
    Fukuhara, Seiichiro
    Hibi, Toshifumi
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (03) : 1643 - 1645